TITLE

FDA ACTS AGAINST DIETARY SUPPLEMENTS CONTAINING ARISTOLOCHIC ACID

PUB. DATE
May 2001
SOURCE
NCAHF Newsletter;May/Jun2001, Vol. 24 Issue 3, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports the demand of the United States Food and Drug Administration on consumers to discontinue use of dietary supplements with aristolochic acid. Link of aristolochic acid with kidney damage and cancer; Identification of products with aristolochic acid.
ACCESSION #
5924284

 

Related Articles

  • Vitamins: Fact or fiction?  // Restaurant Business;8/10/93, Vol. 92 Issue 12, p132 

    Reports on the Food and Drug Administration (FDA) proposal to crackdown on the dietary supplement industry. Reaction by dietary supplement manufacturers and users; Evaluation of products with questionable nutritional value; Chaparral; L-tryptophan; Guar gum; Germanium.

  • "The Sky is Falling, the Sky is Falling" (maybe some of it is). Czap, Al // Alternative Medicine Review;Sep2011, Vol. 16 Issue 3, p209 

    The author comments on the guidelines issued by the U.S. Food and Drug Administration (FDA) concerning the release and marketing of new dietary ingredients (NDI) on July 2, 2011. He says that the guidelines emphasize that the essential proof to identify that an ingredient was marketed in the...

  • DMAA Causes More NDI Issues.  // Nutraceuticals World;Jun2012, Vol. 15 Issue 5, p18 

    The article reports on the move of the U.S. Food and Drug Administration (FDA) in issuing warning letters to marketers of ,3-dimethylamylamine (DMAA)-containing dietary supplements.

  • Supplements: What the FDA doesn't tell you. Block, Gladys // Consumers' Research Magazine;Feb94, Vol. 77 Issue 2, p19 

    Part II. Looks at statistics of the vitamin intake of Americans. The fraction of Americans who take a dietary supplement daily; Comparisons with vitamin intake in 1987; Concerns of the Food and Drug Administration (FDA) regarding the use of vitamins; The issue of toxicity; Public policy and...

  • Adverse events system near for supplements.  // Medical Marketing & Media;Sep2002, Vol. 37 Issue 9, p34 

    Reports on the development of an adverse event (AE) system for dietary supplements by the U.S. Food and Drug Administration. Completion of the pilot testing for the AE system; Usability of the system on capturing and analyzing consumer complaints; Importance of the system on improving the...

  • Appendix II: Data on FDA's Consumer Protection Actions Related to Dietary Supplements.  // GAO Reports;3/18/2013, p52 

    An appendix is presented with respect to the combined data collected during the review with data from a prior report to provide added detail on the U.S. Food and Drug Administration (FDA)'s actions to identify and respond to safety concerns related to dietary supplements.

  • FDA to clarigy claims for diet supplements. Smith, Elizabeth A. // Drug Topics;6/1/98, Vol. 142 Issue 11, p42 

    Reports that in 1998 the United States Food and Drug Administration (FDA) offered clarification on claims made by manufacturers of dietary supplements about the potential of their products. Circumstances under which products are considered drugs; Types of products which do not require clearance...

  • Flight 483 now boarding. Czap, AI // Alternative Medicine Review;Sep2010, Vol. 15 Issue 3, p183 

    The author reflects on the nature of pharmaceutical companies that are seemingly unregulated. A discussion of the actions taken by the U.S. Food and Drug Administration (FDA) to protect the public from poorly made products and bring changes to better manufacturing quality is presented. It looks...

  • Report: FDA lacks info on supplements.  // Medical Marketing & Media;Jun2001, Vol. 36 Issue 6, p30 

    Focuses on the need for the Food and Drug Administration to present sufficient information on dietary supplements in the U.S.

  • FDA guidelines on dietary supplements.  // NCRHI Newsletter;Sep/Oct98, Vol. 21 Issue 4, p3 

    Deals with the September-October 1998 `FDA Consumer' report which contains `An FDA Guide to Dietary Supplements.' Overview of the what the article implies; Comments on the United States Food & Drug Administration.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics